71 related articles for article (PubMed ID: 38551384)
1. Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.
Ezquer F; Bruna F; Calligaris S; Conget P; Ezquer M
World J Gastroenterol; 2016 Jan; 22(1):24-36. PubMed ID: 26755858
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages.
Huai Q; Zhu C; Zhang X; Dai H; Li X; Wang H
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551384
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury.
Shahror RA; Ali AAA; Wu CC; Chiang YH; Chen KY
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142002
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.
Desai BN; Singhal G; Watanabe M; Stevanovic D; Lundasen T; Fisher FM; Mather ML; Vardeh HG; Douris N; Adams AC; Nasser IA; FitzGerald GA; Flier JS; Skarke C; Maratos-Flier E
Mol Metab; 2017 Nov; 6(11):1395-1406. PubMed ID: 29107287
[TBL] [Abstract][Full Text] [Related]
5. Tgr5-/- mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling.
Pokhrel S; Dilts M; Stahl Z; Boehme S; Frame G; Chiang JYL; Ferrell JM
Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37185802
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice.
Xue B; Xiao X; Yu T; Xiao X; Xie J; Ji Q; Wang L; Na T; Meng S; Qian L; Duan H
Stem Cell Res Ther; 2021 Feb; 12(1):133. PubMed ID: 33588950
[TBL] [Abstract][Full Text] [Related]
7. Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease.
Han J; Lee C; Hur J; Jung Y
Cells; 2022 Dec; 12(1):. PubMed ID: 36611816
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Harrison SA; Frias JP; Neff G; Abrams GA; Lucas KJ; Sanchez W; Gogia S; Sheikh MY; Behling C; Bedossa P; Shao L; Chan D; Fong E; de Temple B; Shringarpure R; Tillman EJ; Rolph T; Cheng A; Yale K;
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1080-1093. PubMed ID: 37802088
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications.
Huai Q; Zhu C; Zhang X; Dai H; Li X; Wang H
Cell Biosci; 2023 Sep; 13(1):162. PubMed ID: 37670393
[TBL] [Abstract][Full Text] [Related]
10. GDF15 Ameliorates Liver Fibrosis by Metabolic Reprogramming of Macrophages to Acquire Anti-Inflammatory Properties.
Li X; Huai Q; Zhu C; Zhang X; Xu W; Dai H; Wang H
Cell Mol Gastroenterol Hepatol; 2023; 16(5):711-734. PubMed ID: 37499753
[TBL] [Abstract][Full Text] [Related]
11. FGF21 counteracts alcohol intoxication by activating the noradrenergic nervous system.
Choi M; Schneeberger M; Fan W; Bugde A; Gautron L; Vale K; Hammer RE; Zhang Y; Friedman JM; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2023 Mar; 35(3):429-437.e5. PubMed ID: 36889282
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment.
Yang X; Li Q; Liu W; Zong C; Wei L; Shi Y; Han Z
Cell Mol Immunol; 2023 Jun; 20(6):583-599. PubMed ID: 36823236
[TBL] [Abstract][Full Text] [Related]
13. Alcohol-Associated Hepatitis.
Bataller R; Arab JP; Shah VH
N Engl J Med; 2022 Dec; 387(26):2436-2448. PubMed ID: 36577100
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
